Nov 07, 2022 4:10pm EST New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing
Nov 03, 2022 4:05pm EDT Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule
Oct 19, 2022 8:10am EDT Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation
Oct 18, 2022 4:15pm EDT Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022
Sep 13, 2022 8:00am EDT TriLink BioTechnologies, Part of Maravai LifeSciences, Expands its mRNA Raw Material Offering with the First GMP-grade Modified Nucleoside-Triphosphate Product
Aug 04, 2022 4:51pm EDT CORRECTION: Maravai Lifesciences Reports Second Quarter 2022 Financial Results
